Fibromyalgia
Widespread pain with fatigue and sleep disruption. Covered indirectly by the chronic pain and sleep findings.
What the evidence says
Not separately assessed by NASEM. Inherits substantial evidence for chronic pain and moderate evidence for sleep disturbance associated with fibromyalgia specifically.
Fibromyalgia sits at an interesting intersection: it is a chronic pain condition, and it is one of the four conditions named in the NASEM sleep finding. Both of those evidence lines apply.
What does not exist is a fibromyalgia-specific NASEM conclusion. The support is inherited from the broader chronic pain and sleep findings rather than direct.
Given the fatigue component, many people find a CBD-forward daytime approach with a THC-forward evening dose works better than a single all-day product.
What to ask for
This is a starting point, not a prescription. Take it to a licensed dispensary and ask to see the batch certificate of analysis.
- Suggested ratio
- CBD-forward by day, THC-forward at night
- Starting THC dose
- 2.5 mg
- Commonly chosen profile
- Balanced hybrid
- Time of day
- either
Cannabinoids
- CBD
Non-intoxicating. The only cannabis-derived compound with an FDA-approved medicine behind it, and the cannabinoid most often used to soften THC.
- THC
The main intoxicating compound in cannabis. It drives most of what people mean by "high," and it is also the cannabinoid behind most documented therapeutic effects.
Terpenes to look for
Commonly present in products people choose for this. Terpene effect claims are preclinical — this is a way to find a product again, not a promise about how it will feel.
- Beta-caryophyllene
Peppery, woody, spicy
- Myrcene
Earthy, musky, faintly sweet
- Linalool
Floral, lavender, slightly spicy
Formats
- TinctureOnset 15–90 min · lasts 4–8 h
Liquid extract dosed by dropper. The most precise way to titrate an oral dose in small increments.
- CapsuleOnset 30–120 min · lasts 6–8 h
Swallowed softgel or capsule. Behaves like an edible with pharmacy-style consistency.
- TopicalOnset 15–60 min · lasts 2–6 h
Creams, balms, and patches applied to skin. Non-transdermal topicals do not produce intoxication.
Get a personalised starting point
Answer four questions and we will adjust the dose for your experience level and find licensed dispensaries near you.
Get guidanceTalk to a doctor if
- • You have not had a fibromyalgia diagnosis confirmed
- • You have new neurological symptoms
Related conditions
- Chronic painPain lasting more than three months. The single indication with the strongest evidence base for cannabis in adults.
- Neuropathic painPain from nerve damage — burning, shooting, or electric in quality. Covered by the chronic pain finding.
- ArthritisJoint pain and inflammation. Covered by the chronic pain finding.
- MigraineRecurrent severe headache. Insufficient evidence specifically for migraine, despite widespread claims.
Sources
- NASEM 2017, Committee Conclusions (summary PDF of all evidence-tier conclusions).Accessed 2026-08-15.
- Bhaskar A, Bell A, Boivin M, et al. Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process. Journal of Cannabis Research. 2021;3(1):22.(DOI 10.1186/s42238-021-00073-1 / PMID 34215346)Accessed 2026-08-15.